"Global Cancer Stem Cell Therapy Market, Price, Dosage and Clinical Trial Insight 2025" Report Highlights:
Role and Mechanism Of Stem Cells In Cancer Treatment
Stem Cell Transplantation In Cancer Treatment
Global Bone Marrow Transplant Market Opportunity : > US$ 15 Billion
Global Cord Blood Transplant Market Opportunity
Cancer Stem Cell Therapy Clinical Pipeline: 37 Therapies
Majority Stem Cells In Preclinical Phase: 18 Therapies
Cancer Stem Cell Therapy Clinical Pipeline by Country: More Than 30 In USA
Post Therapy Cancer Stem Cell Targeting Drugs
Cancer incidences are escalating as a result of which demand for better therapeutics is increasing across the globe. There are several products in cancer market which have sufficiently high pharmacological efficiency and offers severe competition to other therapeutics belonging to same indication. Several cancer therapeutics have been developed in past years but they tend to become less effective in long-term. This creates large unmet medical needs as patients are not treated well despite the presence of suitable therapeutics. Cancer stem cell therapeutics are expected to change this scenario as they act on the very basis of development of cancer cells.
Innovations in pharmaceutical industry seem to be the main driving force for the development of cancer stem cell therapies. Investigators have been able to identify different stem cell sources which offers them large base for developing new therapies. Their customizability and appropriate usage is expected to help them to discover new pharmacological properties that may have high commercialization potential. As a result, large numbers of cancer stem cell therapies are entering in clinical trials across the globe.
Clinical pipeline of cancer stem cells therapies is quite strong due to which multiple number of products are expected to be launched in global market in coming years. Development of stem cell therapies for CNS and CVS disorders has already gained lots of attention by investigators. Large population base and rapidly escalating cancer incidences are main factors behind growth of such investigational therapies. Budding stem cell therapies like development of cure for diabetes are also gaining momentum in past years. Less number of competitors is expected to increase the profit margins and allow cancer stem cell therapy developers to occupy major market shares. More stem cell therapies having high pharmacological and commercialization potential has yet to be discovered.
Several pharmaceutical companies are trying to develop different type of products that could target and eliminated cancer stem cells from the body. New candidates are at different stages of clinical trials which are expected to produce positive results. They are at different stages of clinical trials and they are expected to take some time before entering in market. Different methods are being studied targeting different mechanism by which cancer stem cells survive in the body. Different signaling pathways have been identified that play an important role in development of cancer stem cells.
The global stem cell therapy market is expected to witness favorable growth in future driven by the exponential increase in the research and development activities along with launch of 2 or more commercial stem cell therapies over a period of next 5 - 8 years. The shifting thrust towards targeted approach for cancer treatment will also create favorable environment for the development of stem cell therapies and will drive the overall market to new horizon in coming years.
5.1 Stem Cell As Suicide Gene Therapy 5.2 Stem Cell As Vehicle for Oncolytic Viruses 5.3 Stem Cells In Post Cancer Treatment 5.4 Stem Cells As Nanoparticle Carriers
6. Mechanism Of Cancer Stem Cell Targeting Drug
6.1 Targeting The Molecular Signaling Pathway 6.2 Targeting Cancer Stem Cell Markers 6.3 Targeting Cancer Stem Cell Niche and Quiescent State 6.4 Targeting The miRNA Expression 6.5 Inducing Cancer Stem Cell Apoptosis 6.6 Induction Of Cancer Stem Cell Differentiation
7. Stem Cell Transplantation In Cancer Treatment
7.1 Mechanism Of Action Of Stem Cell Transplantation
7.2 Types Of Stem Cell Transplants In Cancer Treatment 7.2.1 Autologous Stem Cell Transplantation 7.2.2 Allogeneic Stem Cell Transplantation 7.2.3 Syngeneic Stem Cell Transplantation
8. Post Therapy Cancer Stem Cell Targeting Drugs
8.1 Stem Cell Therapeutics In Skin Cancer 8.1.1 Erivedge 8.1.2 Odomzo
8.2 Stem Cell Therapeutics In Leukemia 8.2.1 Daurismo
8.3 Cancer Stem Cell Therapeutics In Colon Cancer 8.3.1 Sulindac
8.4 Cancer Stem Cell Therapeutics In Breast Cancer
8.5 Stem Cell Therapeutics In Other Cancer 8.5.1 Vorinostat 8.5.2 Belinostat 8.5.3 Romidepsine 8.5.4 Panabiostat
9. Hematopoietic Stem Cell Transplant Market
9.1 Bone Marrow Transplant Market and Cost Analysis 9.2 Cord Blood Transplant Market
10. Global Cancer Stem Cell Clinical Pipeline By Company, Indication and Phase
11.1 Current Market Scenario 11.2 Clinical Pipeline
12. Personalized Stem Cell Cancer Therapy
12.1 Overview 12.2 Advantages of Personalized Stem Cell Cancer Therapy
13. Personalized Stem Cell Cancer Therapy by Indication
13.1 Glioblastoma 13.1.1 Lung Cancer 13.1.2 Acute Myeloid Leukemia and Melanoma 13.1.3 Ovarian and Breast Cancer 13.1.4 Pancreatic Cancer
14. Global Stem Cell Market Dynamics Challenges and Drivers
14.1 Challenges of Cancer Stem Cell Therapeutics 14.2 Global Cancer Stem Cell Therapeutics Market Drivers
15. Global Cancer Stem Cell Therapy Market Future Outlook
16. Competitive Landscape
16.1 Aelan Cell Technologies 16.2 Baylx 16.3 Benitec Biopharma 16.4 BlueRock Therapeutics 16.5 Calidi Biotherapeutics 16.6 Cellular Dynamics International 16.7 Center for iPS Cell Research and Application 16.8 Century Therapeutics 16.9 Khloris Biosciences 16.10 ReNeuron
Figure 1-1: Research History on Stem Cell Figure 2-1: Types of Stem Cells Figure 4-1: Advantages of Stem Cell Therapies Figure 5-1: Stem Cell Mediated Suicide Gene Therapy System Figure 6-1 Different Molecular Signaling Pathways of Stem Cells Figure 6-2: Mechanism of Stem Cell Therapeutics via Targeting Surface Markers Figure 6-3: Mechanism by Inducing Cancer Stem Cell Apoptosis Figure 6-4: Mechanism by Inducing Differentiation of Cancer Stem Cell Figure 7-1: Mechanism of Action of Cancer Stem Cell Transplantation Figure 7-2: Types of Stem Cell Transplantation Figure 8-1: Erivedge - Patent on Product Type Figure 8-2: Erivedge - Patent on Anticancer Property Figure 8-3: Erivedge- Price for 28 Capsule Supply and Price per Unit (US$), July’2019 Figure 8-4: Odomzo Patent on Product Type Figure 8-5: Odomzo Patent for Anticancer Property Figure 8-6: Odomzo- Price for 30 Capsule Supply and Price per Unit (US$), July’2019 Figure 8-7: Daurismo- Price for 30 Tablets of 25mg and 100 mg Oral Tablet (US$), July’2019 Figure 8-8: Daurismo: Price per Tablet of 25 mg and 100 Mg Tablet (US$), July’2019 Figure 8-9: Sulindac: Price for 100 Tablet Supply of 150 mg and 200 mg (US$), July’2019 Figure 8-10: Sulindac: Per Unit Cost of 150 mg and 200 mg Tablet (US$), July 2019 Figure 8-11: Zolinza - Patent Issued In Different Years Figure 8-12: Zolinza- Price for 120 Capsule Supplies Of 100mg and Price per Unit (US$), July’2019 Figure 813: Beleodaq - Patent Issued and Expiration Year for First Patent Figure 8-14: Beleodaq - Patent Issued and Expiration Year for Second Patent Figure 8-15: Istodax: Patent Issued and Expiration Year Figure 9-1: Cost of Different Bone Marrow Transplant (US$ Million), July’2019 Figure 9-2: Bone Marrow Transplant Market (US$ Billion), 2018 - 2025 Figure 9-3: Global - Autologous v/s Allogeneic Bone Marrow Transplant Market(%), 2019 Figure 9-4: Global - Cord Blood Transplant Market (US$ Million), 2018-2025 Figure 11-1: Global - Cancer Stem Cell Therapeutics Market Opportunity (US$ Billion), 2019 - 2025 Figure 11-2: Global - Cancer Stem Cell Therapy Clinical Pipeline (%), 2019 till 2025 Figure 11-3: Global - Cancer Stem Cell Therapy Clinical Pipeline (Number of Trials), 2019 till 2025 Figure 11-4: Global - Cancer Stem Cell Therapy Clinical Pipeline by Country (Number of Trials), 2019 till 2025 Figure 11-5: Global - Cancer Stem Cell Therapy Clinical Pipeline by Company (Number of Trials), 2019 till 2025 Figure 12-1: Steps of Personalised Stem Cell Cancer Therapy Figure 14-1: Challenges of Cancer Stem Cell Therapeutics Figure 14-2: Drivers of Cancer Stem Cell Therapeutics Figure 16-1: Baylx - Clinical Pipeline Figure 16-2: Benitec Bioparma - Clinical Pipeline Figure 16-3: BlueRock Therapeutics - Clinical Pipeline Figure 16-4: Calidi Biotherapeutics - Clinical Pipeline
Need custom market research solution? We can help you with that too.
Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and
service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers
understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas.